Contents 110
materials and how they could underpin a new generation of medical devices.
104 Choosing the right medical device component manufacturer Custom Wire Technologies
107 Particular expertise, manufacturing excellence CaP Biomaterials
109 The tubing experts that save time and money MicroSpec
Biomaterials
110 A toothbrush for a knee In many cases, severe knee osteoarthritis is treated at an advanced age through replacing the knee joint. But prior to this point there’s very little in the way of treatment, and with cases of osteoarthritis increasing among younger patients, many must live with pain, discomfort and at times limited mobility for years before they can undergo joint replacement surgery. Mesenchymal stem cells have been touted as a potential treatment before the disease reaches this point, but extracting, culturing and delivering them to patients comes with its own challenges. Dennis McGonagle, professor of investigative rheumatology at the Leeds Institute of Rheumatic and Musculoskeletal Medicine, is part of a team that invented a device to try
10
and overcome these challenges and make the treatment more viable for patients. He speaks to Mae Losasso to explain how it works.
113 Advanced absorbable implants, faster to market Poly-Med, Inc.
115 The compliance countdown: Are you ready for the new MDR? Rousselot
Coatings & surface treatment
116 Keeping microbes at bay The vectors for microbial transmission are numerous in hospitals. Items such as catheters, intravenous bags and devices, dialysis tubing, disposable syringes, gloves, implanted devices and hospital beds all carry the risk of a nosocomial infection. Despite enhanced cleaning regimes, several microbial species can survive in a hospital setting. To find ways to reduce this risk, researchers are constantly experimenting with coatings that have been physically or chemically designed to prevent the spread of pathogens or kill them on contact. But how did we reach the stage of knowledge we’re at now, with numerous coatings leveraging different mechanisms of action available? Peter Littlejohns explores how infection control has evolved throughout history, and why antimicrobial coatings haven’t become a core part of the field control yet.
119 Providing the coating that medical devices need Formacoat
Packaging, supply & logistics
122 Top priority Transport disruptions. Labour shortages. Bad weather. The pandemic. There are many ways of understanding the sluggish supply chains of today’s medical device sector, but together they are having a profound impact on manufacturers and patient care. Agility is therefore critical to supply chain resiliency and reliability, which is why the medical device industry association AdvaMed is advocating for policy changes to make medical devices a supply chain priority. Andrea Valentino speaks to Scott Whitaker and Abby Pratt from AdvaMed to learn more, along the way exploring how private-public partnerships could be the way forward.
126 Seal of approval
As sterility must be ensured to offset the risk of infection for patients, packaging engineers often recommend designing medical devices with the packaging in mind, rather than it leaving it as an afterthought. Elly Earls speaks to Dan Burgess, fellow of packaging engineering at Boston Scientific, on what some of his key considerations are when taking this design approach and how new regulations and technology could impact the packaging process in the years ahead
Events
130 Events to look out for in 2023/24
132 The future of healthcare and the evolving role of sensor technology COMPAMED 2023
134 Product showcase 141 Suppliers guide
Medical Device Developments /
www.nsmedicaldevices.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146
